Ready to rumble: Roche scores Rozlytrek OK to challenge Bayer—and undercuts it on price

·

·

Ready to rumble: Roche scores Rozlytrek OK to challenge Bayer—and undercuts it on price

Roche’s targeted cancer drug Rozlytrek is officially cleared for U.S. launch—and in not one, but two indications. Thursday, the FDA green-lighted the medication to treat adults with ROS1-positive non-small cell lung cancer. Separately, it approved the product …
See Original Article

The bombshell report accusing GE of 'Enronesque' fraud is just the latest in the company's long …

The recent report by Harry Markopolos alleging fraud by General Electric is the latest in a legacy of accounting controversies the company has faced.
See Original Article

SPAM is jumping on the pumpkin spice bandwagon. Really.

HONOLULU, Hawaii (KGMB/KHNL) – As fall approaches, more and more companies are announcing their holiday-themed products. Yes, pumpkin spice SPAM is real and it’s hitting shelves next month. (Source: SPAM/Facebook). But here’s one you probably …
See Original Article

If There's a Recession, It Will Be Made in China

It's official — the yield curve has now definitely inverted, meaning that one of the most reliable signals of an impending recession is now flashing
See Original Article

Tanzania clears Acacia to resume exports from largest gold mine

Acacia Mining said the Tanzanian government had allowed it to resume gold exports from its largest mine in the country. The London-listed company said Tanzania’s Ministry of Minerals had authorised exports from its North Mara Gold mine following a …
See Original Article



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.